Aaremms - I think you maybe right.
I reckon PRR will quickly catch the imagination of the US biotech investor and the DNDN story will by nature further push interest. Lets hope anyway.
Cheers
comparison with dendreon - sp acceleration, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $551.9M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $1.296M | 3.401M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54900 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 22008 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |